Mile Brujic is encouraged by the data of emerging presbyopia solutions, knowing that the details matter for presbyopic patients. “Details matter when it comes to vision. Extending depth of focus through reducing pupil size makes me optimistic for my presbyopic patients.” Are you following the latest research? Visit us at www.EyeAmSelective.com to learn more. #EyeAmSelective #Presbyopia
LENZ Therapeutics’ Post
More Relevant Posts
-
Read how we helped identify a cohort of 10,000+ patients for analysis to help Ocular Therapeutix, Inc. better understand how #DEXTENZA was being used in the real world. Download the case study today: https://hubs.la/Q02hppdv0
To view or add a comment, sign in
-
-
Upcoming Webinar Series: "Advancing Periorbital Treatments: The Teoxane Approach" We are thrilled to announce our exclusive webinar series, with invaluable insights from top experts in the field of periorbital treatments. For for the first session Dr. Lee Walker and Dr Philippe Berros will share their extensive experience in periorbital treatments. Learn about the integration of Redensity 2 into their practices, and how they've evolved their techniques for better patient outcomes. Expect to walk away with expert takeaways, personal experiences, and practical tips! In our second session, delve deeper into strategies for avoiding and managing complications in periorbital treatments with Dr. Sabrina Shah-Desai. Building on the insights from Webinar 1, this discussion will equip you with the knowledge to navigate challenges effectively. 🔗 Registration links : Webinar 1: https://lnkd.in/exvVigVC Webinar 2: https://lnkd.in/e7Eck9eB #Webinar #Teoxane #PeriorbitalTreatments #MedicalAesthetics #ExpertInsights #Redensity2 #ContinuingEducation #ProfessionalDevelopment
To view or add a comment, sign in
-
How can you engage more patients in your research? 🫂 Join the upcoming Community of Practice session to learn strategies, challenges and implications of patient engagement in primary sclerosing cholangitis research. https://buff.ly/44p3vFh #PatientEngagement
To view or add a comment, sign in
-
-
🚀 Exciting News from Yale New Haven Health & Aidoc at the 2024 Vascular Annual Meeting! 🌟 See below how Aidoc AI is transforming patient care! 🏥💡 🌟 Highlights: - Improved Detection: Aidoc’s AI identifies critical follow-up cases often missed. - Efficiency Boost: At Yale, follow-up clinic volumes nearly doubled, intervention times dropped from 270 to 58 days, and aneurysm rupture rates fell by 62%! - Seamless Integration: Aidoc’s aiOS™ platform integrates with EHRs for comprehensive patient care. Aidoc’s technology bridges gaps in follow-up care, ensuring timely, effective treatments. #HealthcareInnovation #AIinHealthcare #PatientCare #VAM2024 #AidocAI
🔴 #vam24 announcement! New data from Yale New Haven Health demonstrates how AI impacts aortic patient management with the following clinical results: 💉 increased appropriate interventions by 14% ⏲️ Decreased time to intervention from 270 to 58 days ⬇️ Reduced aneurysm rupture rate reduced by 62% Learn more about this case study and our aortic care products from our team of vascular AI experts down at booth #900. Get the full story here 👉 https://okt.to/T6ywEB #vascular
To view or add a comment, sign in
-
-
Ruptured aortic aneurysms cause 5,000 deaths in the UK each year. They are most common in men over 65 - they are responsible for 1 in 75 deaths of men in this age group. - https://lnkd.in/eKwY24hD #aaa, #aorticaneurysm, #ai, Aidoc #availablenowintheuk #turningaiintoaction Want to know what happens when you deploy AI at multiple points across the patient pathway? Want to see what is possible when you deploy an AI Platform instead of a marketplace? See 👇
🔴 #vam24 announcement! New data from Yale New Haven Health demonstrates how AI impacts aortic patient management with the following clinical results: 💉 increased appropriate interventions by 14% ⏲️ Decreased time to intervention from 270 to 58 days ⬇️ Reduced aneurysm rupture rate reduced by 62% Learn more about this case study and our aortic care products from our team of vascular AI experts down at booth #900. Get the full story here 👉 https://okt.to/T6ywEB #vascular
To view or add a comment, sign in
-
-
🌐#FYA2024 Symposium On-Demand Ep. 14 🔓Unlock key skills in arterial management 📽️Watch in full here👉 https://ow.ly/jyqe50RHWwn 🌟Dr Hany Zayed discusses the use of deep venous arterialisation in no-option patients, outlining patient selections and strategies, procedural steps and follow-up.
To view or add a comment, sign in
-
Automation to optimize your workflow! Sign up and join us for the next webinar
Upcoming webinar for European clinicians! Don't miss our upcoming 30-minute webinar on the future of treatment planning. Learn how automation can optimize your workflow, leading to faster, top-quality patient treatment plans. Get insights from a clinic that's embraced Radformation's solutions and have all your automation questions answered. Secure your spot today: https://bit.ly/3SprvVC #radiationoncology #webinar #medphys #medicalphysics
To view or add a comment, sign in
-
-
This course will cover the variety of contact lens options for correction of vision in keratoconus patients. It will go through the decision-making process between the various lenses, what factors influence those choices, and the basics on how to achieve success with each modality in a case-based format. Register now! Here is the link to register: https://lnkd.in/gzq4H98H #ContactLensOptions #Keratoconus #VisionCorrection #DecisionMaking #CaseBasedLearning #RegisterNow #Optometry #OptometryEducation #KeratoconusLearning
To view or add a comment, sign in
-
-
Comparison of laparoscopic versus open appendectomy results elderly patients: Scoping review Seyed Vahid Seyed Hosseini Volume 3, Issue 1 , January 2024, Pages 61-71 https://lnkd.in/dWa8jpYD
To view or add a comment, sign in
-
Comparison of laparoscopic versus open appendectomy results elderly patients: Scoping review Seyed Vahid Seyed Hosseini Volume 3, Issue 1 , January 2024, Pages 61-71 https://lnkd.in/d7rvEY8y
To view or add a comment, sign in